Pilot trial of devices to extract clot from occluded arteries (PISTE)
On February 11 2015, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
At present it is not clear how best to organise NHS services so that patients can benefit from thrombectomy for stroke. The Institute of Heath Services, Newcastle University, has produced an online survey to understand the preferences of stroke survivors, their carers and the public on the future of stroke thrombectomy service organisation in the UK.
Currently, a drug called alteplase is used in thrombolysis, but the researchers think that another drug, called tenecteplase, may be more effective than alteplase.
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
Two more studies support (thrombectomy) mechanical clot retrieval for stroke.
Exploring the effects of lowering blood pressure and a lower dose of clot busting drug on stroke outcome
Promising research results for a new drug treatment for ischaemic stroke patients have been published today in the journal ‘Lancet Neurology’.